Entity > Corporation > US > New York City New York > Gilead Sciences
About Gilead Sciences
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Gilead Sciences
| Company Attribute | Value |
| Name | Gilead Sciences |
| Url | gilead |
| Wikipedia | wikipedia |
| Wikidata | wikidata |
Gilead Sciences
New York City, US
16 Sep 2023
Gilead Sciences
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.gilead.com/
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Rich Sitelinks
People Also Ask
https://www.linkedin.com › company › gilead-sciences
Gilead Sciences. Biotechnology Research. Foster City, CA 567,787 followers. Creating Possible. See jobs Follow.
https://twitter.com/GileadSciences?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://en.wikipedia.org › wiki › Gilead_Sciences
Gilead Sciences, Inc is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral ...
News
Image Boxes
https://www.facebook.com › GileadSciences
Gilead Sciences, Foster City, California. 22822 likes · 100 talking about this. Gilead is a research-based biopharmaceutical company that discovers,...
https://www.cnbc.com › quotes › GILD
Gilead Sciences Inc GILD:NASDAQ ; Last | 2:37 PM EDT. 76.86 quote price arrow down -0.18 (-0.23%) ; Volume. 1,667,313 ; 52 week range. 61.44 - 89.74 ...
Related Searches
gilead sciences careers
gilead sciences address
who owns gilead sciences
Knowledge Panel
Gilead Sciences (Pharmaceutics company)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
-
Stock price : GILD (NASDAQ) $75.67 -1.69 (-2.18%)Sep 15, 4:00 PM EDT - Disclaimer
-
Headquarters : Foster City, CA
-
CEO : Daniel O'Day (Mar 1, 2019–)
-
Revenue : 24.69 billion USD (2020)
-
Subsidiaries : Kite Pharma, Immunomedics, MiroBio Ltd, MORE
-
Founded : June 22, 1987, Foster City, CA
-
CFO : Andrew Dickinson
-
Founder : Michael L. Riordan
| Entity Home | Kalicube Pro Entity Page |
| Gilead Sciences Entity Home | Gilead Sciences on Kalicube |
| Amgen Entity Home | Amgen on Kalicube |
| Bristol Myers Squibb Entity Home | Bristol Myers Squibb on Kalicube |
| Genentech Entity Home | Genentech on Kalicube |
| Gilead Sciences Entity Home | Gilead Sciences on Kalicube |
| Genentech Entity Home | Genentech on Kalicube |
| Sanofi Entity Home | Sanofi on Kalicube |